{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:17Z","timestamp":1791994577899,"version":"4.4.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003366"],"award-info":[{"award-number":["82003366"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000223"],"award-info":[{"award-number":["82000223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.abd.2025.501263","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:16:25Z","timestamp":1768461385000},"page":"501263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["BLyS\/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer"],"prefix":"10.1016","volume":"101","author":[{"given":"Weiyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-5897","authenticated-orcid":false,"given":"Yamin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2025.501263_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16679","article-title":"Targeting therapy in pemphigus: where are we now and where are we going?","volume":"9","author":"Abulikemu","year":"2023","journal-title":"Heliyon."},{"key":"10.1016\/j.abd.2025.501263_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/08923973.2021.1973493","article-title":"Telitacicept as a BLyS\/APRIL dual inhibitor for autoimmune disease","volume":"43","author":"Shi","year":"2021","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"10.1016\/j.abd.2025.501263_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/bjd\/ljac118","article-title":"Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study","volume":"188","author":"Kridin","year":"2023","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2025.501263_bib0020","article-title":"Telitacicept, a human recombinant fusion protein targeting B Lymphocyte Stimulator (BlyS) and a Proliferation-Inducing Ligand (APRIL), in Systemic Lupus Erythematosus (SLE): results of a phase 3 study [Internet]","volume":"74","author":"Wu","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.abd.2025.501263_bib0025","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard-2022-223529","article-title":"BLyS\/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept","volume":"82","author":"Cai","year":"2023","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.abd.2025.501263_bib0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ekir.2022.12.014","article-title":"Randomized phase 2 trial of telitacicept in patients with IgA nephropathy with persistent proteinuria","volume":"8","author":"Lv","year":"2023","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.abd.2025.501263_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1298650","article-title":"Combination treatment with telitacicept, cyclophosphamide and glucocorticoids for severe granulomatous polyangiitis: a case report and literature review","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2025.501263_bib0040","article-title":"Case report: successful treatment of refractory membranous nephropathy with telitacicept","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2025.501263_bib0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/rheumatology\/kead265","article-title":"Efficacy and safety of telitacicept in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial","volume":"63","author":"Xu","year":"2024","journal-title":"Rheumatology."},{"key":"10.1016\/j.abd.2025.501263_bib0050","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00415-023-12036-y","article-title":"Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report","volume":"271","author":"Zhang","year":"2024","journal-title":"J Neurol."},{"key":"10.1016\/j.abd.2025.501263_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1279808","article-title":"Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies","volume":"14","author":"Ren","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2025.501263_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets","volume":"39","author":"Glass","year":"2022","journal-title":"Cell Rep."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625002053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625002053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:37:02Z","timestamp":1773963422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059625002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0365059625002053"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2025.501263","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BLyS\/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2025.501263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501263"}}